• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24110 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Open magnetic resonance imaging (MRI) scanners
2007     HAYES, Inc. Open malabsorptive bariatric Surgery: roux-en-y gastric bypass
2020     National Institute for Health and Care Excellence (NICE) Open prenatal repair for open neural tube defects in the fetus. NICE interventional procedures guidance 668
2015     National Institute for Health and Care Excellence (NICE) Open reduction of slipped capital femoral epiphysis. NICE interventional procedures guidance 511
2007     HAYES, Inc. Open restrictive bariatric surgery: gastroplasty and gastric banding
2017     HAYES, Inc. Open sacroiliac joint fusion for unspecified sacroiliac joint dysfunction
2014     HAYES, Inc. Open surgery for sacroiliac joint fusion for the treatment of low back pain
2020     NIHR Health Technology Assessment programme Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT
2010     NIHR Health Technology Assessment programme Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010     Quality Improvement Scotland (NHS QIS ) Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy for localised prostate cancer
2013     Scottish Health Technologies Group (SHTG) Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy for localised prostate cancer.
2012     Institute for Clinical Evaluative Sciences (ICES) Opening eyes, opening minds: the Ontario burden of mental illness and addictions report
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines
2021     Penn Medicine Center for Evidence-based Practice (CEP) Opioid pain assessment
2020     Agency for Healthcare Research and Quality (AHRQ) Opioid treatments for chronic pain
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2003     WorkSafeBC Opioid use in chronic non-cancer pain: proposal for a common approach across Canada
2014     Penn Medicine Center for Evidence-based Practice (CEP) Opioid-induced sedation scales
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid-sparing effects of IV acetaminophen for patients undergoing surgery
2015     NIHR Health Technology Assessment programme Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness
2021     Penn Medicine Center for Evidence-based Practice (CEP) Opioids for vaso-occlusive crisis in pregnant patients
2007     Adelaide Health Technology Assessment (AHTA) Opportunistic screening of asymptomatic individuals for Chlamydia
2025     NIHR Health and Social Care Delivery Program Opportunities and practices supporting responsive health care for forced migrants: lessons from transnational practice and a mixed-methods systematic review
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Opportunities and strategies to drive appropriate use of MRI in Austria
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Opportunity costs associated with technology expansion in the MUHC
1999     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening program for genetic hemochromatosis
1995     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening program of Hemochromatosis in France
1999     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening programme for deafness in the newborn
2003     Medical Services Advisory Committee (MSAC) Optical biometry using partial coherence interferometry prior to cataract surgery
2008     Medical Services Advisory Committee (MSAC) Optical coherence tomography
2016     HAYES, Inc. Optical Coherence Tomography (OCT) for plaque characterization and stent implantation
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2015     Medical Services Advisory Committee (MSAC) Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2009     Medical Advisory Secretariat (MAS) Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis
2011     HAYES, Inc. Optical coherence tomography for coronary artery plaque characterization and stent evaluation
2003     Alberta Heritage Foundation for Medical Research (AHFMR) Optical coherence tomography for diagnosing retinal disease
2008     Adelaide Health Technology Assessment (AHTA) Optical coherence tomography for MS prognosis
2002     NIHR Horizon Scanning Centre (NIHR HSC) Optical coherence tomography for the diagnosis of eye disorders - horizon scanning review
2014     NIHR Health Technology Assessment programme Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: an evidence-based analysis
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: OHTAC recommendation
2007     Haute Autorite de sante (HAS) Optical coherence tomography of the posterior pole of the eye
2014     National Institute for Health and Care Excellence (NICE) Optical coherence tomography to guide percutaneous coronary intervention. NICE interventional procedures guidance 481
2013     Medical Services Advisory Committee (MSAC) Optical coherence tomography, for the diagnosis and monitoring of treatment effectiveness with aflibercept in patients with central retinal vein occlusion (co-dependent)
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Optical coherence tomography. Systematic review
2003     VA Technology Assessment Program (VATAP) Optical devices for adults with low vision: a systematic review of published studies of effectiveness
2000     VA Technology Assessment Program (VATAP) Optical lens fabrication systems
2022     National Institute for Health and Care Excellence (NICE) Optilume for treating recurrent bulbar urethral strictures. NICE medical technologies guidance 73
2016     NIHR Health Technology Assessment programme OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
2016     NIHR Health Technology Assessment programme OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2007     Medical Advisory Secretariat (MAS) Optimal health system design for preventive health screening
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal method for driving assessment in older adults and in patients who have had a cerebrovascular accident: clinical evidence, cost-effectiveness, and guidelines
2017     NIHR Health Services and Delivery Research programme Optimal NHS service delivery to care homes: a realist evaluation of the features and mechanisms that support effective working for the continuing care of older people in residential settings
2013     Health Quality Ontario (HQO) Optimal onset-to-admission interval for inpatient stroke rehabilitation: a rapid review
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pharmacotherapy for transplant ineligible multiple myeloma
2022     NIHR Health Technology Assessment programme Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal screening procedures prior to physician visits: guidelines
2014     NIHR Health Technology Assessment programme Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness
2015     NIHR Health Technology Assessment programme Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal strategies for the diagnosis of acute pulmonary embolism: a health technology assessment
2021     NIHR Health Technology Assessment programme Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model
2003     VA Technology Assessment Program (VATAP) Optimal temperature for cardioplegia during coronary artery bypass grafting: a systematic review of published randomized controlled trials for myocardial protection
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal timing and frequency of follow-up care for patients receiving at-home supplemental oxygen: clinical evidence and guidelines
2013     Health Quality Ontario (HQO) Optimal timing for antibiotic administration in patients with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing of hip fracture surgery: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing to begin an active rehabilitation program after a hip fracture: a rapid review
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal use of minimally invasive glaucoma surgery: a health technology assessment
2025     NIHR Health Services and Delivery Research programme Optimisation of the deployment of automated external defibrillators in public places in England
2020     NIHR Health Services and Delivery Research programme Optimising acute care for people with dementia: a mixed-methods study
2025     NIHR Health and Social Care Delivery Program Optimising neonatal services for very preterm births between 27+0 and 31+6 weeks gestation in England: the OPTI-PREM mixed-methods study
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Optimization of diagnosis of fertility disorders - primary research
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Optimization of diagnostic management of suspected lung embolism - primary research
2013     Health Quality Ontario (HQO) Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) OPTIMIZER™ system for chronic heart failure
2015     Institute of Health Economics (IHE) Optimizing adoption and diffusion of medical devices at the system level
2013     Health Quality Ontario (HQO) Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework
2013     Health Quality Ontario (HQO) Optimizing chronic disease management mega-analysis: economic evaluation
2023     Institute of Health Economics (IHE) Optimizing MRI service capacity: review of the relationship between MRI delay and outcomes
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2022     Institute of Health Economics (IHE) Optimizing the use of low back pain and spine condition-related interventions and procedures
2021     Institute of Health Economics (IHE) Optimizing vascular risk reduction initiatives in Alberta: a clinical review and economic analysis
2006     Medical Advisory Secretariat (MAS) Optimum methadone compliance testing: an evidence-based analysis
2002     Centre for Clinical Effectiveness (CCE) Optimum number of consecutive nights for shift workers
2014     Agency for Healthcare Research and Quality (AHRQ) Options for developing a web-based forum on patient registries
2001     University HealthSystem Consortium (UHC) Options for osteoporosis
2018     NIHR Health Technology Assessment programme Options for possible changes to the blood donation service: health economics modelling
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2006     NIHR Horizon Scanning Centre (NIHR HSC) Optiscope for internal examinations and surgical operations: horizon scanning technology note
2011     HAYES, Inc. OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2000     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices for the detection of cervical cancer - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices in screening for cervical cancer - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic low vision aids for the visually impaired - horizon scanning review
2023     Agency for Care Effectiveness (ACE) Optune for the treatment of newly diagnosed and recurrent glioblastoma
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral alitretinoin for adults with chronic hand eczema
2001     NIHR Horizon Scanning Centre (NIHR HSC) Oral and buccal insulin for diabetes - horizon scanning review
2008     NIHR Horizon Scanning Centre (NIHR HSC) Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III